Literature DB >> 2176746

Regulation of progesterone receptor-mediated transcription by phosphorylation.

L A Denner1, N L Weigel, B L Maxwell, W T Schrader, B W O'Malley.   

Abstract

The progesterone receptor (PR) in the chicken oviduct is a phosphoprotein that regulates gene transcription in the presence of progesterone. Treatment with progesterone in vivo stimulates phosphorylation of the progesterone receptor. With transient transfection assays, the present work has tested whether phosphorylation participates in the regulation of PR-mediated transcription. Treatment with 8-bromo-cyclic adenosine monophosphate (8-Br cAMP), a stimulator of cAMP-dependent protein kinase [protein kinase A (PKA)], mimicked progesterone-dependent, receptor-mediated transcription in the absence of progesterone. Inhibition of PKA blocked hormone action. Treatment with okadaic acid, an inhibitor of protein phosphatases 1 and 2A, stimulated transcription in a manner similar to that of progesterone. These observations suggest that phosphorylation of the PR or other proteins in the transcription complex can modulate PR-mediated transcription in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176746     DOI: 10.1126/science.2176746

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  79 in total

1.  Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

Authors:  V Doucas; Y Shi; S Miyamoto; A West; I Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Differential modes of activation define orphan subclasses within the steroid/thyroid receptor superfamily.

Authors:  J P Lydon; R F Power; O M Conneely
Journal:  Gene Expr       Date:  1992

Review 3.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

Review 4.  Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data.

Authors:  Roberto Romero; Kypros Nicolaides; Agustin Conde-Agudelo; Ann Tabor; John M O'Brien; Elcin Cetingoz; Eduardo Da Fonseca; George W Creasy; Katharina Klein; Line Rode; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2011-12-11       Impact factor: 8.661

5.  The COUP-TFs compose a family of functionally related transcription factors.

Authors:  L H Wang; N H Ing; S Y Tsai; B W O'Malley; M J Tsai
Journal:  Gene Expr       Date:  1991

6.  Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.

Authors:  S W Curtis; T Washburn; C Sewall; R DiAugustine; J Lindzey; J F Couse; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

7.  Phosphorylation of immunopurified rat liver glucocorticoid receptor by the catalytic subunit of cAMP-dependent protein kinase.

Authors:  T Haske; M Nakao; V K Moudgil
Journal:  Mol Cell Biochem       Date:  1994-03-30       Impact factor: 3.396

8.  Activation of androgen receptor function by a novel nuclear protein kinase.

Authors:  A M Moilanen; U Karvonen; H Poukka; O A Jänne; J J Palvimo
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

9.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.

Authors:  G Bunone; P A Briand; R J Miksicek; D Picard
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

10.  Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.

Authors:  C L Smith; O M Conneely; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.